Cargando…

Advances in HIV-1 Vaccine Development

An efficacious HIV-1 vaccine is regarded as the best way to halt the ongoing HIV-1 epidemic. However, despite significant efforts to develop a safe and effective vaccine, the modestly protective RV144 trial remains the only efficacy trial to provide some level of protection against HIV-1 acquisition...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Yong, McKay, Paul F., Mann, Jamie F. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923461/ https://www.ncbi.nlm.nih.gov/pubmed/29614779 http://dx.doi.org/10.3390/v10040167

Ejemplares similares

Eradication of HIV-1 latent reservoirs through therapeutic vaccination
por: Pankrac, Joshua, et al.
Publicado: (2017)

Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1
por: Gao, Yong, et al.
Publicado: (2018)

An Overview of Rift Valley Fever Vaccine Development Strategies
por: Kitandwe, Paul Kato, et al.
Publicado: (2022)

Blocking T‐cell egress with FTY720 extends DNA vaccine expression but reduces immunogenicity
por: Mann, Jamie F. S., et al.
Publicado: (2021)

Plasmid DNA Vaccine Co-Immunisation Modulates Cellular and Humoral Immune Responses Induced by Intranasal Inoculation in Mice
por: King, Deborah F. L., et al.
Publicado: (2015)

Glucopyranosyl Lipid A Adjuvant Significantly Enhances HIV Specific T and B Cell Responses Elicited by a DNA-MVA-Protein Vaccine Regimen
por: McKay, Paul F., et al.
Publicado: (2014)

Pulmonary delivery of DNA vaccine constructs using deacylated PEI elicits immune responses and protects against viral challenge infection()
por: Mann, Jamie F.S., et al.
Publicado: (2013)

Transferrin conjugation confers mucosal molecular targeting to a model HIV-1 trimeric gp140 vaccine antigen()
por: Mann, J.F.S., et al.
Publicado: (2012)

TLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN Routes
por: McKay, Paul F., et al.
Publicado: (2016)

Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination
por: Kratochvil, Sven, et al.
Publicado: (2017)

Corrigendum: Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination
por: Kratochvil, Sven, et al.
Publicado: (2018)

Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune Correlates
por: Tomaras, Georgia D., et al.
Publicado: (2013)

HIV-1 vaccine immunogen design strategies
por: Mann, Jaclyn K, et al.
Publicado: (2015)

Intravaginal immunisation using a novel antigen-releasing ring device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses
por: McKay, Paul F., et al.
Publicado: (2017)

Molecular Signatures of a TLR4 Agonist-Adjuvanted HIV-1 Vaccine Candidate in Humans
por: Anderson, Jenna, et al.
Publicado: (2018)

Advances in Antibody-Based HIV-1 Vaccines Development
por: Dietrich, Ursula
Publicado: (2020)

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
por: Ahmed, Yousuf, et al.
Publicado: (2017)

A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infection
por: Mann, Jamie F.S., et al.
Publicado: (2020)

Next-generation COVID-19 vaccines: here come the proteins
por: Blakney, Anna K, et al.
Publicado: (2021)

Development of prophylactic vaccines against HIV-1
por: Schiffner, Torben, et al.
Publicado: (2013)

Development of targeted adjuvants for HIV-1 vaccines
por: Liu, Jun, et al.
Publicado: (2017)

Advances in the management of erythropoietic protoporphyria – role of afamelanotide
por: Lane, Ashley M, et al.
Publicado: (2016)

Antibody‐virus co‐evolution in HIV infection: paths for HIV vaccine development
por: Bonsignori, Mattia, et al.
Publicado: (2017)

Mucosal Application of gp140 Encoding DNA Polyplexes to Different Tissues Results in Altered Immunological Outcomes in Mice
por: Mann, Jamie F. S., et al.
Publicado: (2013)

Discrete partitioning of HIV-1 Env forms revealed by viral capture
por: Stieh, Daniel J., et al.
Publicado: (2015)

Advances in HIV-1 Assembly
por: Lerner, Grigoriy, et al.
Publicado: (2022)

Family-based HIV prevention and intervention services for youth living in poverty-affected contexts: the CHAMP model of collaborative, evidence-informed programme development
por: Bhana, Arvin, et al.
Publicado: (2010)

Expressing anti-HIV VRC01 antibody using the murine IgG1 secretion signal in Pichia pastoris
por: Aw, Rochelle, et al.
Publicado: (2017)

Recent Advances in Applications of Hybrid Graphene Materials for Metals Removal from Wastewater
por: Abu-Nada, Abdulrahman, et al.
Publicado: (2020)

Developments in HIV-1 immunotherapy and therapeutic vaccination
por: Smith, Peter Lawrence, et al.
Publicado: (2014)

Leishmania Immunity: Advancing Immunotherapy and Vaccine Development
por: Ikeogu, Nnamdi M., et al.
Publicado: (2020)

Recent Advances in HIV-1 Gag Inhibitor Design and Development
por: Dick, Alexej, et al.
Publicado: (2020)

Artificial intelligence in the prediction of protein–ligand interactions: recent advances and future directions
por: Dhakal, Ashwin, et al.
Publicado: (2021)

HIV Vaccination: A Roadmap among Advancements and Concerns
por: Trovato, Maria, et al.
Publicado: (2018)

Current progress in the development of a prophylactic vaccine for HIV-1
por: Gamble, Lena J, et al.
Publicado: (2010)

A Zigzag but Upward Way to Develop an HIV-1 Vaccine
por: Wen, Ziyu, et al.
Publicado: (2020)

A global approach to HIV-1 vaccine development
por: Stephenson, Kathryn E, et al.
Publicado: (2013)

Killed whole-HIV vaccine; employing a well established strategy for antiviral vaccines
por: Kang, C. Yong, et al.
Publicado: (2017)

DNA Immunization for HIV Vaccine Development
por: Chen, Yuxin, et al.
Publicado: (2014)

Key advances in vaccine development for tuberculosis—success and challenges
por: Lai, Rocky, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rt6b2e2sfnvr6llv5dfvdd9og4